The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.

Slides:



Advertisements
Similar presentations
The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Advertisements

The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
ECG The Acute Coronary Syndromes
The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
The Macstrak Project Ward Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Keith A A Fox Royal Infirmary & University of Edinburgh CURE and PCI-CURE.
Treatment of Acute Coronary Syndrome with ST elevation ESC guidelines 2008 Dr. David Tran A&E dept. FVH 22/12/09.
CHEST PAIN Belgian Inter disciplinary Working group of Acute Cardiology Claeys MJ Vandekerckhove Y Bossaert L Calle P Martens P Hollanders G Vrints C Van.
“ If physicians would read two articles per day out of the six million medical articles published annually, in one year, they would fall 82 centuries behind.
The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Management of Acute Myocardial Infarction Minimal Acceptable vs Optimal Care Hussien H. Rizk, MD Cairo University.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
Current and Future Perspectives on Acute Coronary Syndromes Paul W. Armstrong MD AMI Quebec Montreal October 1, 2010.
Myocardial Infarction
The Macstrak Project Ward Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Acute Coronary Syndrome. Acute Coronary Syndrome (ACS) Definition of ACS Signs and symptoms of ACS Gender and age related difference in ACS Pathophysiology.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
‘Taxi Driver in Pain’ Tiara Gill Carrie Ross Mark Hambly.
Chest Pain & Unstable Angina Eugene Yevstratov MD Based on UCLA protocol of the management of Chest Pain & Unstable Angina.
ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.
VBWG OASIS-5 The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
ACS and Thrombosis in the Emergency Setting
Tuesday Conference Myocardial Infarction Diagnosis and management.
Amy Gutman MD EMS Medication Director
Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland.
DR. ZAHOOR 1.  A 50 year old man presents to clinic with a complaint of central chest discomfort of 2 weeks’ duration, occurring after walking for more.
APPROACH TO CHEST PAIN. OBJECTIVES  1. Establish a differential diagnosis for chest pain  2. Know what clues to obtain on history to rule-in or out.
The Broken Heart Syndrome Primary Care Conference May 30, 2007 Gregory L. Sheehy, M.D.
ACS Clinical Pathway. Who? Pts with Acute Ischemic Heart Disease now described as having ACS.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
TREATMENT OF ACUTE MYOCARDIAL INFARCTION NUR 351/352 PROFESSOR DIANE E. WHITE RN MS CCRN.
“Challenging practice in non-ST segment elevation Acute Coronary Syndromes (ACS)” Professor Jennifer Adgey Royal Victoria Hospital, Belfast 26th January.
Acute Coronary Syndrome
Diagnosis, Management, & Follow-up Care Of CAD/AMI BARRY BERTOLET, MD CARDIOLOGY ASSOCIATES OF NORTH MS.
The INT egrelin and E noxaparin R andomized assessment of A cute C oronary syndrome Treatment T rial Sponsored by the Canadian Heart Research Centre, Key.
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
Acute Coronary Syndromes in West Hertfordshire Masood Khan.
Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
1 Advanced Angioplasty London, England 27 January, 2006 Jörg Michael Rustige,MD Medical Director Lilly Critical Care Europe, Geneva.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
VBWG OASIS-6 The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
{ Challenging Case Presentations From South Texas Methodist Hospital REGIONAL SYSTEMS OF CARE DEMONSTRATION PROJECT: MISSION: LIFELINE™ STEMI SYSTEMS ACCELERATOR.
SPEED : GUSTO-IV PILOT GUSTO-IV Pilot Trial. SPEED : GUSTO-IV PILOT Rationale for Combination Therapy in AMI Enhance Incidence and Speed of Reperfusion.
Acute Coronary Syndrome
A Clinical profile of patients enrolled in the Pakistan ACS registry
Cangrelor Case Presentations
Risk Stratification of Chest Pain: Best Practices
CORONARY ARTERY DISEASE
The European Society of Cardiology Presented by Dr. Saman Rasoul
Ischaemic Heart Disease Acute Coronary Syndrome
R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R
Unstable Angina and Non–ST Elevation Myocardial Infarction
Chapter 28 Management of Patients With Coronary Vascular Disorders
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
The following slides are based on a presentation at a Satellite Symposium in association with the Annual Cardiovascular Conference at Lake Louise, Alberta,
The European Society of Cardiology Presented by RJ De Winter
What oral antiplatelet therapy would you choose?
Infarct Size after Primary Angioplasty Patients With Bivalirudin
Train-the-Trainer Cases
CRITICAL/CLINICAL PATHWAYS ACUTE CORONARY SYNDROMES
R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R
Presentation transcript:

The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form. The information is provided in sequence to reflect the natural progression of a patient’s care. As the case is presented, mark off the required information in the appropriate fields on your Macstrak form. At the end of each case study, the form will be reviewed with the correct answers supplied. If you have any questions, please refer to your Macstrak manual or contact us at the Macstrak Project Office.

The Macstrak Project CCU Case Study

The Macstrak Project CCU Case Study KFD is a 62-year-old (DOB:09/09/43) woman with no significant past medical history.

The Macstrak Project CCU Case Study KFD is a 62-year-old (DOB:09/09/43) woman with no significant past medical history. On the afternoon of 08/02/06 KFD is brought to the ER at 13:30 by her husband. She reports chest pain for the past 3 hours associated with nausea and diaphoresis. She is seen by the triage RN on arrival and her vital signs are as follows: BP 145/80, HR 96 and chest is clear. KFD continues to have chest pain which she rates at 9/10. An ECG is done at 13:43 showing ST elevation in II/IIIaVF and ST depression in V 1 -V 4. The ER MD assesses KFD and finds she has no contraindications to reperfusion therapy. At 13:50 the decision is made to treat KFD (weight 59 kg) with TNK.

The Macstrak Project CCU Case Study 30 mg of TNK over 5 seconds is given at 14:00. KFD also receives UF heparin IV and metoprolol IV.

The Macstrak Project CCU Case Study 30 mg of TNK over 5 seconds is given at 14:00. KFD also receives UF heparin IV and metoprolol IV. By 15:00 the pain remains and an ECG shows persistent ST segment elevation.

The Macstrak Project CCU Case Study 30 mg of TNK over 5 seconds is given at 14:00. KFD also receives UF heparin IV and metoprolol IV. By 15:00 the pain remains and an ECG shows persistent ST segment elevation. At 15:15, KFD is transferred from your hospital to a tertiary hospital for a rescue PCI. She arrives at the cath lab at 16:00 and angiography confirms a persistent occlusion of the right coronary artery. She has a successful angioplasty with her first inflation at 16:35.

The Macstrak Project CCU Case Study KFD arrives back at your hospital at 23:00 and is admitted to your CCU with a diagnosis of Acute Myocardial Infarction. She has eptifibitide (Integrilin ® ) infusing intravenously on arrival. She was loaded with clopidogrel 600 mg at the other hospital and is now on 75 mg per day. The eptifibitide is discontinued the next morning. Her CK and troponins are positive. KFD has no further chest pain or complications while in CCU.

The Macstrak Project CCU Case Study KFD is discharged to the cardiac ward on 11/02/06 at 09:00. Her discharge diagnosis is Acute Myocardial Infarction and her peak CK is 2206 and peak troponin is 32. She is discharged on the following medications: ASA clopidogrel bisoprolol ramipril atorvastatin

The Macstrak Project Centre: CCU ICU Date: 20 Day Month Year Patient Initials: F M L Birth Date: 19 Day Month Year Gender: Male Female CCU Case Study KFD is a 62-year-old (DOB:09/09/43) woman with no significant past medical history. K F D CCU MACSTRAK X

The Macstrak Project Centre: CCU ICU Date: 20 Day Month Year Patient Initials: F M L Birth Date: 19 Day Month Year Gender: Male Female CCU Case Study KFD is a 62-year-old (DOB:09/09/43) woman with no significant past medical history. CCU MACSTRAK On the afternoon of 08/02/06 KFD is brought to the ER at 13:30 by her husband. She reports chest pain for the past 3 hours associated with nausea and diaphoresis X K F D

The Macstrak Project Past Medical History : 30 days MI ……………………………. Angina ……………………….. CABG ……………………….. PCI …………………………… CHF ………………………….. TIA/CVA …………………….. Diabetes (oral agents/insulin)... None of the Above……………. CCU Case Study KFD is a 62-year-old (DOB:09/09/43) woman with no significant past medical history. X

The Macstrak Project Patient Origin: ER EMS Walk In Dr.’s Office/Clinic (Direct) Other Hospital Inpatient Medical Ward Surgical Ward Other ICU Other: ……………… CCU Case Study On the afternoon of 08/02/06 KFD is brought to the ER at 13:30 by her husband. She reports chest pain for the past 3 hours associated with nausea and diaphoresis. X X

The Macstrak Project VS at Presentation: (complete for all patients) Dyspnea/Rales: None Mild Mod/Severe Systolic BP: < >190 Heart Rate: < >100 CCU Case Study On the afternoon of 08/02/06 KFD is brought to the ER at 13:30 by her husband. She reports chest pain for the past 3 hours associated with nausea and diaphoresis. She is seen by the triage RN on arrival and her vital signs are as follows: BP 145/80, HR 96 and chest is clear. KFD continues to have chest pain which she rates at 9/10. X X X

The Macstrak Project CCU Case Study KFD arrives back at your hospital at 23:00 and is admitted to your CCU with a diagnosis of Acute Myocardial Infarction. She has eptifibitide (Integrilin ® ) infusing intravenously on arrival. She was loaded with clopidogrel 600 mg at the other hospital and is now on 75 mg per day. The eptifibitide is discontinued the to next morning. Her CK and troponins are positive. KFD has no further chest pain or complications while in CCU. Admitting Diagnosis: (Check one only) Acute AMI (48 hrs) UA R/O MI UA RSCP NYD CHF Arrhythmia Aortic Dissection Non ACS Pericardial Disease Other: ………………… ACS X

The Macstrak Project CCU Case Study Symptom Onset : EMS at Scene: Timeline: (AMI pts only - 24 hr clock or > 24 hrs) Hospital Arrival: First ECG: EMS Diagnostic ECG: 1030 On the afternoon of 08/02/06 KFD is brought to the ER at 13:30 by her husband. She reports chest pain for the past 3 hours associated with nausea and diaphoresis. She is seen by the triage RN on arrival and her vital signs are as follows: BP 145/80, HR 96 and chest is clear. KFD continues to have chest pain which she rates at 9/10. An ECG is done at 13:43 showing ST elevation in II/IIIaVF and ST depression in V 1 -V

The Macstrak Project Diagnostic ECG: (ACS pts. only) ST  ST  T  Q No ACS ST-TV 5-6 ……….… … ….. …... PacedII/IIIaVF ….. … ….. ….... OtherV 4 R..done... V 7-9..done... CCU Case Study V 1-4 ………….. …..… …... LBBB IaVL ………... ….…. …… KFD continues to have chest pain which she rates at 9/10. An ECG is done at 13:43 showing ST elevation in II/IIIaVF and ST depression in V 1 -V 4. X X X

The Macstrak Project Reperfusion Therapy: No  Not Indicated:  ECG Not Diag. ST Up Transient Too Late Given (Other Hosp) Risk:  Risk of ICB Risk Other Bleed Other: …………… Drug:TNK/rtPA SK r-PA ( reteplase ) Other Adjuvant: ASA Heparin GP2b/3a Inhibitor  blocker IV Clopidogrel Other and/or Primary/Rescue PCI  Here Transfer Reperfusion Therapy Decided by:EP Consultant CCU Case Study Yes  Thrombolysis  Here EMS Other Hosp Dose: (mg/units) Duration: (min) Pt.Weight: (kg) The ER MD assesses KFD and finds she has no contraindications to reperfusion therapy. At 13:50 the decision is made to treat KFD (weight 59 kg) with TNK. X X X X X 59

The Macstrak Project Reperfusion Therapy: No  Not Indicated:  ECG Not Diag. ST Up Transient Too Late Given (Other Hosp) Risk:  Risk of ICB Risk Other Bleed Other: …………… Drug:TNK/rtPA SK r-PA ( reteplase ) Other Adjuvant: ASA Heparin GP2b/3a Inhibitor  blocker IV Clopidogrel Other and/or Primary/Rescue PCI  Here Transfer Reperfusion Therapy Decided by:EP Consultant CCU Case Study Yes  Thrombolysis  Here EMS Other Hosp Dose: (mg/units) Duration: (min) Pt.Weight: (kg) 30 mg of TNK over 5 seconds is given at 14:00. KFD also receives UF heparin IV and metoprolol IV. X X X X X X X

The Macstrak Project Reperfusion Therapy: No  Not Indicated:  ECG Not Diag. ST Up Transient Too Late Given (Other Hosp) Risk:  Risk of ICB Risk Other Bleed Other: …………… Drug:TNK/rtPA SK r-PA ( reteplase ) Other Adjuvant: ASA Heparin GP2b/3a Inhibitor  blocker IV Clopidogrel Other and/or Primary/Rescue PCI  Here Transfer Reperfusion Therapy Decided by:EP Consultant CCU Case Study Yes  Thrombolysis  Here EMS Other Hosp Dose: (mg/units) Duration: (min) Pt.Weight: (kg) At 15:15, KFD is transferred from your hospital to a tertiary hospital for a rescue PCI. She arrives at the cath lab at 16:00 and angiography confirms a persistent occlusion of the right coronary artery. X X X X X X X X X

The Macstrak Project CCU Case Study At 13:50 the decision is made to treat KFD (weight 59 kg) with TNK. TLysis Started: Arrive Lab: First Inflation: TLysis Ordered: GP 2b/3a Started: Transfer: mg of TNK over 5 seconds is given at 14:

The Macstrak Project CCU Case Study At 13:50 the decision is made to treat KFD (weight 59 kg) with TNK. TLysis Started: Arrive Lab: First Inflation: TLysis Ordered: GP 2b/3a Started: Transfer: mg of TNK over 5 seconds is given at 14: At 15:15, KFD is transferred from your hospital to a tertiary hospital for a rescue PCI. She arrives at the cath lab at 16:00 and angiography confirms a persistent occlusion of the right coronary artery. She has a successful angioplasty with her first inflation at 16:

The Macstrak Project Acuity: Shift: Diuretics……………………… Inotropes IV………………….. ETT/Vent…………………….. PA Line………………………. TTVP………………………… IABP…………………………. ACS: RSCP - Ischemia – Definite…. – Probable… CK (+ve)………………...…… Troponin (+ve)……………….. NTG IV………………………. Heparin – UFH……………..... – LMWH……………. Other Antithrombin………...… GP 2b/3a Inhibitor IV……...… Clopidogrel (or ticlopidine)..… Cardiac Cath……………….... PCI…………………………... Outcomes: VF/Sustained VT………….… Infarction (new/repeat) *(1) …... Thrombolysis (new/repeat) *(2).. Stroke *(3) ……………………. Major Bleed *(4) ……………… Transfusion………………….. Crs1: ……………………….... Crs2: ……………………..….. None of the Above……….….. RN Initials ………………..…. Date: CCU Case Study DNDNN D KFD arrives back at your hospital at 23:00 and is admitted to your CCU with a diagnosis of Acute Myocardial Infarction. She has eptifibitide (Integrilin ® ) infusing intravenously on arrival. She was loaded with clopidogrel 600 mg at the other hospital and is now on 75 mg per day. The eptifibitide is discontinued the next morning. Her CK and troponins are positive. KFD has no further chest pain or complications while in CCU SG AW D N 11 PJ CS X XX XX XXX X XX X X X

The Macstrak Project Discharge Diagnosis: Acute MI Unstable Angina Chest Pain NYD CHF Arrhythmia Other Cardiac Problem: ………… Non Cardiac Problem: …..… ………..... Date: 20 Time: CCU Case Study KFD is discharged to the cardiac ward on 11/02/06 at 09:00. Her discharge diagnosis is Acute Myocardial Infarction and her peak CK is 2206 and peak troponin is 32. She is discharged on the following medications: ASA clopidogrel bisoprolol ramipril atorvastatin Day Month Year Peak CK: Trop: X

The Macstrak Project CCU Case Study KFD is discharged to the cardiac ward on 11/02/06 at 09:00. Her discharge diagnosis is Acute Myocardial Infarction and her peak CK is 2206 and peak troponin is 32. She is discharged on the following medications: ASA clopidogrel bisoprolol ramipril atorvastatin Discharged To: Cardiac Ward Med/Surg Ward Step Down Unit CV Surgery Other ICU Other Hospital Home Death Other: Discharge Meds: ASA Clopidogrel (or ticlop.) Heparin (UF or LMW) Nitrates (po/top) B Blocker ACEI A2 Blocker Statin None of Above X X X X X X